GB0002527D0 - Use of vascular endothelial growth factor (VEGF) placental growth factor (PLGF)or both for the treatment of ischemic and acute myocardial infaction - Google Patents

Use of vascular endothelial growth factor (VEGF) placental growth factor (PLGF)or both for the treatment of ischemic and acute myocardial infaction

Info

Publication number
GB0002527D0
GB0002527D0 GB0002527A GB0002527A GB0002527D0 GB 0002527 D0 GB0002527 D0 GB 0002527D0 GB 0002527 A GB0002527 A GB 0002527A GB 0002527 A GB0002527 A GB 0002527A GB 0002527 D0 GB0002527 D0 GB 0002527D0
Authority
GB
United Kingdom
Prior art keywords
growth factor
plgf
vegf
ischemic
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0002527A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CTG
Katholieke Universiteit Leuven
Vlaams Instituut voor Biotechnologie VIB
Original Assignee
CTG
Katholieke Universiteit Leuven
Vlaams Instituut voor Biotechnologie VIB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CTG, Katholieke Universiteit Leuven, Vlaams Instituut voor Biotechnologie VIB filed Critical CTG
Priority to GB0002527A priority Critical patent/GB0002527D0/en
Publication of GB0002527D0 publication Critical patent/GB0002527D0/en
Priority to PCT/EP2001/001659 priority patent/WO2001057181A2/en
Priority to AU46435/01A priority patent/AU4643501A/en
Priority to AU2001230243A priority patent/AU2001230243A1/en
Priority to JP2001556492A priority patent/JP4969753B2/en
Priority to PCT/EP2001/001208 priority patent/WO2001056593A2/en
Priority to DE60119285T priority patent/DE60119285T2/en
Priority to AT01902406T priority patent/ATE324905T1/en
Priority to EP01902406A priority patent/EP1253935B1/en
Priority to DK01902406T priority patent/DK1253935T3/en
Priority to PT01902406T priority patent/PT1253935E/en
Priority to US10/182,359 priority patent/US6930089B2/en
Priority to ES01902406T priority patent/ES2263582T3/en
Priority to US11/471,823 priority patent/US7727971B2/en
Ceased legal-status Critical Current

Links

GB0002527A 2000-02-04 2000-02-04 Use of vascular endothelial growth factor (VEGF) placental growth factor (PLGF)or both for the treatment of ischemic and acute myocardial infaction Ceased GB0002527D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GB0002527A GB0002527D0 (en) 2000-02-04 2000-02-04 Use of vascular endothelial growth factor (VEGF) placental growth factor (PLGF)or both for the treatment of ischemic and acute myocardial infaction
PCT/EP2001/001659 WO2001057181A2 (en) 2000-02-04 2001-02-02 Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
AU46435/01A AU4643501A (en) 2000-02-04 2001-02-02 Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
ES01902406T ES2263582T3 (en) 2000-02-04 2001-02-05 USE OF THE GROWTH FACTOR TO PREVENT OR TREAT ISCHEMICAL CARDIOPATIAS OR CARDIOVASCULAR ACCIDENTS.
DE60119285T DE60119285T2 (en) 2000-02-04 2001-02-05 USE OF PLGF TO PREVENT OR TREAT ISCHAEMIE OR HITCH
JP2001556492A JP4969753B2 (en) 2000-02-04 2001-02-05 Pharmaceutical composition for reducing infarct size during treatment of ischemic disease
PCT/EP2001/001208 WO2001056593A2 (en) 2000-02-04 2001-02-05 Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
AU2001230243A AU2001230243A1 (en) 2000-02-04 2001-02-05 Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
AT01902406T ATE324905T1 (en) 2000-02-04 2001-02-05 USE OF PLGF TO PREVENT OR TREAT SCHAEMIA OR STROKE
EP01902406A EP1253935B1 (en) 2000-02-04 2001-02-05 Use of placenta growth factor for preventing or treating ischemic diseases or stroke
DK01902406T DK1253935T3 (en) 2000-02-04 2001-02-05 Use of placental growth factor to prevent or treat ischemic disease or stroke
PT01902406T PT1253935E (en) 2000-02-04 2001-02-05 CABINET SCREW ESPECIALLY ADAPTED TO A PRESSURE AND FITTING POINT
US10/182,359 US6930089B2 (en) 2000-02-04 2001-02-05 Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic disease or stroke
US11/471,823 US7727971B2 (en) 2000-02-04 2006-06-21 Use of placental growth factor for treating ischemic muscle disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0002527A GB0002527D0 (en) 2000-02-04 2000-02-04 Use of vascular endothelial growth factor (VEGF) placental growth factor (PLGF)or both for the treatment of ischemic and acute myocardial infaction

Publications (1)

Publication Number Publication Date
GB0002527D0 true GB0002527D0 (en) 2000-03-29

Family

ID=9884925

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0002527A Ceased GB0002527D0 (en) 2000-02-04 2000-02-04 Use of vascular endothelial growth factor (VEGF) placental growth factor (PLGF)or both for the treatment of ischemic and acute myocardial infaction

Country Status (1)

Country Link
GB (1) GB0002527D0 (en)

Similar Documents

Publication Publication Date Title
AU2583399A (en) Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
HK1041833A1 (en) Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
IL158546A0 (en) Prevention of myocardial infarction induced ventricular expansion and remodeling
AU3947902A (en) Therapeutic agents and methods of use thereof for the modulation of angiogenesis
AU2001275339A1 (en) Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
PL360742A1 (en) Pyrazole derivatives and their use as protein kinase inhibitors
EE200100480A (en) Xenon for use in the treatment of nerve poisoning
EP1359972A4 (en) Ocular iontophoretic device and method for inhibiting vascular endothelial growth factor (vegf) using the same
EE05281B1 (en) Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction
HUP0200827A2 (en) Vascular endothelial cell growth factor variants and uses thereof
AU2001270484A1 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
HUP0203957A3 (en) Angiogenesis and vascular permeability modulators and inhibitors
EP1204672A4 (en) High affinity vascular endothelial growth factor (vegf) receptor nucleic acid ligands and inhibitors
MXPA03004303A (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain.
EP1194150A4 (en) Use of nitroxides in wound healing and in the prevention of photodamage
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
DE60021360D1 (en) VEGF ANGIOGENIC GROWTH FACTORS FOR THE TREATMENT OF PERIPHERAL NEUROPATHY
GB0002527D0 (en) Use of vascular endothelial growth factor (VEGF) placental growth factor (PLGF)or both for the treatment of ischemic and acute myocardial infaction
EP1200133A4 (en) Manipulation of tissue or organ type using the notch pathway
IL151992A0 (en) Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists
HUP0302241A3 (en) Use of ccr5 antagonist and dp-178 polypeptide for treating viral infections
AU6137801A (en) Method and composition for the treatment of angiogenesis
AU2001230243A1 (en) Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
FI990735A0 (en) Method of evaporating the solution and evaporator used in the method
DE50006845D1 (en) LOCKER ARRANGEMENT FOR THE STORAGE AND DELIVERY OF ITEMS

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)